WO2006120851A1 - Agent for imparting functions to textile products - Google Patents
Agent for imparting functions to textile products Download PDFInfo
- Publication number
- WO2006120851A1 WO2006120851A1 PCT/JP2006/308214 JP2006308214W WO2006120851A1 WO 2006120851 A1 WO2006120851 A1 WO 2006120851A1 JP 2006308214 W JP2006308214 W JP 2006308214W WO 2006120851 A1 WO2006120851 A1 WO 2006120851A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- derivative
- hydroxyproline
- products
- proline
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/322—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen
- D06M13/325—Amines
- D06M13/342—Amino-carboxylic acids; Betaines; Aminosulfonic acids; Sulfo-betaines
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/322—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen
- D06M13/35—Heterocyclic compounds
- D06M13/352—Heterocyclic compounds having five-membered heterocyclic rings
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H27/00—Special paper not otherwise provided for, e.g. made by multi-step processes
- D21H27/002—Tissue paper; Absorbent paper
Definitions
- the present invention relates to a functional imparting agent for a fiber product, a functional fiber product, and a method for producing the functional fiber product, which contains hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof.
- Hydroxyproline an N-acylated derivative of hydroxyproline, or a salt thereof is known as an amino acid exhibiting a moisturizing effect, and has skin-beautifying effects such as skin aging suppression and skin quality improvement as a cosmetic (for example, patent document 1), prevention of pressure ulcer, and therapeutic effects (for example, patent document 2), prevention and improvement of atopic dermatitis (for example, patent document 3), anti-inflammatory, wound healing effect (For example, Non-Patent Document 1) is known.
- Patent Document 4 discloses an agent for imparting functionality to a fiber product containing amino acids
- Patent Document 5 discloses a fiber web.
- amino acids hydroxyproline or hydroxy is disclosed.
- Patent Document 1 International Publication No. OOZ51561 Pamphlet
- Patent Document 2 Pamphlet of International Publication No. 2004Z28531
- Patent Document 3 International Publication No. 02Z6225 Pamphlet
- Patent Document 4 Japanese Patent Application Laid-Open No. 2004-324026
- Patent Document 5 International Publication No. 96Z31644 Pamphlet
- Non-Patent Document 1 Eurobian Medical Research 3rd, 182-188, 1998 Invention Disclosure
- the present invention relates to an excellent function of hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof for a fiber base material widely used for clothes, bedding, paper omgu, etc. An attempt was made to impart the excellent properties of the wood while keeping it intact, providing superior functional fiber products without drastically changing the conventional fiber manufacturing process and properties. The task is to do.
- the gist of the present invention is as follows.
- N-acylated derivative of hydroxyproline is an N-acetylated derivative, an N-propionylated derivative, an N-propylylated derivative or an N-isoptyrylated derivative. Sex imparting agent.
- N-acylated derivative power of hydroxyproline N-acetylated derivative, N-propionylated derivative, N-propylylated derivative or N-isoptyrylated derivative according to item 6 above ⁇ Bedding materials and products, interior materials and products, automotive interior materials and products, and nursing materials and products.
- N-acylated derivative of hydroxyproline is an N-acetylated derivative, an N-propionylated derivative, an N-propylylated derivative or an N-isoptyrylated derivative.
- the fiber product has functions such as moisture retention, skin aging prevention, skin quality improvement and other skin beautifying effects, pressure ulcer prevention, anti-atopic, anti-inflammatory and wound healing effects. It can be granted.
- the hydroxyproline used in the present invention may be any stereoisomer of hydroxyproline.
- proline of hydroxyproline has 8 physical isomers depending on whether it is D-strength L-strength or hydroxyl-position 3 or 4-position, and its stereoisomer is cis-force trans. And deviations of mixtures thereof can also be used in the present invention.
- hydroxyproline examples include cis-4-hydroxy-1-L-proline, cis-1-hydroxy-D-proline, cis-3-hydroxy-L-proline, cis-3-hydroxy-D-proline, trans-4-hydroxy-L-- Examples include proline, trans-4-hydroxy-D-proline, trans-1-hydroxy-L-proline, and trans-3-hydroxy-D phosphorus.
- Hydroxyproline is a kind of amino acid that exists widely in nature as a major constituent amino acid component in collagen and as a constituent amino acid of elastin.
- hydroxyproline acid-hydrolyzes collagen derived from animals such as butterfly. It can be produced by purification by a conventional method.
- Trans-4-hydroxy L-proline is a proline 4-hydroxylase isolated from microorganisms of the genus Amvcolatopsis or Dactvlosporangium (JP-A-7-313179). Can be used.
- cis-3 hydroxyl L proline can be produced using porphyrin 3-position hydroxylase (Japanese Patent Laid-Open No. 7-322885) isolated from Streptomyces genus cattle. Yes, Bioindustry 1, 14 ⁇ , 31 (1997).
- Hydroxyproline produced using the above-mentioned microorganism-derived enzyme has excellent quality. It is more preferable as hydroxyproline used in the present invention.
- Examples of the N-acyl yl derivatives of hydroxyproline used in the present invention include the above-mentioned N-acyl yl derivatives of the various hydroxyproline stereoisomers.
- Examples of the acyl group of the N-acyl derivative include preferably an acyl group having 1 to 24 carbon atoms, more preferably 1 to 12 carbon atoms, and particularly preferably 1 to 6 carbon atoms.
- Honoleminole acetinole, propionyl, butyrinole, isobutyryl, norellinore, pivalol, hexanol, heptanol, otatanyl, nonanoyl, decanol, undecanol, dodecanol, etc.
- Examples of the salt of hydroxyproline or N-acylated derivative of hydroxyproline include alkali metal salts such as sodium, potassium and lithium, alkaline earth metal salts such as calcium and magnesium, ammonium salts, Examples thereof include addition salts of amines such as monoethanolamine, diethanolamine, triethanolamine and triisopropanolamine, and addition salts of basic amino acids such as arginine and lysine.
- N-acyl derivative of hydroxyproline can be prepared by a known method.
- N-acyl derivatives of hydroxyproline are linear or branched saturated fatty acids having 1 to 24 carbon atoms, such as chlorides and bromides using halogenating agents such as salt and phosgene.
- the product can be produced by conversion to a halogenated product such as the above, followed by condensation with hydroxyproline as described above, or conversion of a fatty acid to an acid anhydride followed by reaction with hydroxyproline.
- fatty acids include formic acid, acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, pivalic acid, hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, and undehydroacid.
- a fatty acid such as dodecanoic acid is used alone or in combination.
- the fatty acid is dispersed in a solvent such as methylene chloride, chloroform, carbon tetrachloride, benzene, toluene, xylene, n-hexane, etc., and 1 to 5 times equivalent of a halogenating agent is added thereto to react.
- a solvent such as methylene chloride, chloroform, carbon tetrachloride, benzene, toluene, xylene, n-hexane, etc.
- Examples of the solvent used in the acyl chloride reaction include water, methanol, ethanol, isopropanol, isobutanol, acetone, toluene, tetrahydrofuran, ethyl acetate, N, N dimethylformamide, dimethyl sulfoxide, and the like. May be used alone or in combination.
- hydroxyproline is dissolved or dispersed in a solvent, 0.8 to 2.0 times equivalent of alkaline substance such as sodium hydroxide and potassium hydroxide is dissolved in the solvent as necessary. Alternatively, it may be dispersed.
- N-acylated derivative of hydroxyproline When it is desired to obtain a salt of an N-acylated derivative of hydroxyproline, if the N-acylated derivative of hydroxyproline is obtained in the form of a salt, it can be purified as it is and obtained in a free form. May be dissolved or suspended in a suitable solvent and a base may be added to form a salt.
- N-acylated derivatives of hydroxyproline include, for example, N-acetyl-cis-4-hydroxy-1-L-proline, N-acetylenolysis-1-4-hydroxy-1-D-proline, N- 1-hydroxyl L-proline, N-acetylenic 1-hydroxy D-proline, N-acetylenic trans 4-4-hydroxy L-proline, N-acetylin trans 4-hydroxy D-proline, N-acetylinole trans 3-hydroxyl-proline, N-acetylinole -Trans 3-hydroxy D proline, N-propionyl-cis 4-hydroxy-L-proline, N-propionyl-cis-4-hydroxy-D-proline, N-propionyl-cis 3-hydroxy L proline, N propionyl cis 3 —Hydroxy D—proline, N propionyl trans 4-hydroxy L— Proline, N-propioninoletrans 4-hydroxy D pulin, N-propion
- the function-imparting agent of the present invention preferably contains 0.01 to 30% by weight of hydroxyproline, a hydroxyproline N-acylated derivative or a salt thereof.
- the functionality-imparting agent of the present invention includes, for example, a stabilizer such as hydroxyproline or a N-calyzed derivative of hydroxyproline or a salt thereof of 0.01 to 30 parts by weight, necessary sorbitol or sorbitol. 0.1 to 10 parts by weight, for example, antiseptic of isothiazoline-based antibacterial agents such as 5-clonal 2-methyl-4-isothiazolin-1-one and 2-methyl-4-isothiazolin-1-one compound (trade name: caisson) Preparation is made with 0.05 to 0. 3 parts by weight of the agent, 0.5 to 25 parts by weight of the binder, and 100 parts by weight of water.
- a stabilizer such as hydroxyproline or a N-calyzed derivative of hydroxyproline or a salt thereof of 0.01 to 30 parts by weight, necessary sorbitol or sorbitol.
- 0.1 to 10 parts by weight for example, antiseptic of isothiazoline-based antibacterial agents such as
- the functionality-imparting agent of the present invention further includes peptides, hydroxyproline or amino acid derivatives other than salts of hydroxyproline or its salts, vitamins, ceramides, glycyrrhizic acids of licorice extract, and raspberries. Extract, lavender extract, jasmine extract, peno mint extract, rosemary extract, roman force fir mono extract, eucalyptus extract, hinokitiol, bamboo extract, aloe extract, catechin, grape funoles extract, lemon extract, jojoba oil, olive oil Citrus oil, seaweed extract, squalene, collagen, and at least one selected from the group power that also has glucose strength may be combined.
- Examples of the peptide include silk protein, hive mouth-in, and the like, and examples of the amino acids include glutamic acid, aspartic acid, glycine, cystine, serine, histidine, lysine, arginine, leucine and the like. It is not limited to. As the vitamins, vitamin A, vitamin C, vitamin E, etc. can be used effectively. Examples of the glycyrrhizic acid of Kiss include glycyrrhizic acid, glycyrrhetinic acid, sodium glycyrrhizinate, potassium glycyrrhizinate, and ammonium glycyrrhizinate.
- examples of the raspberries include raspberries and raspberry ketones
- examples of the squalans include squalans and squalene
- examples of the glucose include glucose, xylitol, and erythritol.
- antibacterial agents such as chitin and chitosan may be combined.
- the combination strength S with silk protein, hive mouth-in, screen lantern, and the like, clothing, etc. is particularly preferable because a very characteristic soft and volumey texture can be obtained.
- components such as hydroxyproline or a hydroxyproline N-acyl yl derivative or a salt thereof may be used in a normal state. It may be used as a clathrate or vesicle structure with dextrin.
- the vesicle structure utilizes a surfactant that forms a polymer at a specific concentration.
- the surfactant molecule aggregate that is, the vesicle bag-like bilayer membrane, has an aqueous phase inside. And has an oil phase. In the oil phase, an oily compound or the like is dissolved in a solvent such as benzyl benzoate and held in the oil phase portion of the vesicle structure.
- the functionality-imparting agent of the present invention contains a binder, it can be fixed to a fiber product as it is, and when it does not contain a binder, it can be fixed using a separate binder.
- the binder include acrylic ester-based, for example, Pararesin GH-S manufactured by Ohara Paradum Chemical Co., Ltd., urethane-based binders, for example, Parasol PN-20 manufactured by Ohara Paradum Chemical Co., Ltd., silicone binders such as Toray Silicone Co., Ltd. It is preferable to use Toray Silicone BY22-826 made by the company and other polymers such as fluorine and epoxy.
- the amount of the binder used is preferably 0.5 to 25 parts by weight relative to 0.01 to 30 parts by weight of hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof.
- such a functionality-imparting agent is fixed to a fiber product, and the fiber product is retained.
- Functionality such as moisture, skin aging control and skin improvement, anti-atopy, anti-inflammatory, wound healing effect, pressure ulcer prevention, etc. can be added.
- Use a treatment solution containing a binder attach it to textiles using a known method such as dubbing, padding, coating, spraying, etc., and fix it dry!
- the fiber product to be treated is not particularly limited in terms of the type of fiber, such as yarn, woven fabric, knitted fabric, non-woven fabric, and fiber web, which may be misaligned.
- the adhesion amount of the function-imparting agent to the fiber product is not particularly limited, but is usually about 0.05 to 5% by weight, preferably 1 to 3% by weight in terms of solid content.
- the building materials of the present invention 'bedding materials and products, interior materials and products, automotive interior materials and products, care materials and products are hydroxyproline, N-acylated derivatives of hydroxyproline or salts thereof Indicates fabric, blanket, sheets, chair fabric, carpet, car seat fabric, seat cover, etc., which are bonded to fibers such as cotton ⁇ %, cotton Z polyester blend, hemp Z polyester blend, etc. Any of the hydroxyproline, the N-acylated derivative of hydroxyproline or a salt thereof may be used in the article. It is preferable to use hydroxyproline, acetyl hydroxyproline and the like.
- the garment of the present invention is hydroxyproline or a hydroxyproline N-acylation derivative or a salt thereof made of 100% cotton, 100% polyester, cotton Z polyester blend, 100% nylon, cotton Z nylon blend.
- the cloth ommu, paper ommu, wet tissue, and tissue paper of the present invention use hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof, and cotton woven paper and paper ommu are usually used for the cloth ommu.
- the water-absorbent fats and oils (see Japanese Patent Application Laid-Open No. 9-157543) and the wet tissue are those produced by bonding to paper. It may also be used in combination with antibacterial agents and deodorizers that are highly safe and natural products, antibacterial agents such as silver colloids, and deodorants.
- Cloth, paper, wet tissue, tissue paper Any hydroxyproline or hydroxyproline N-acylated derivative or salt thereof may be used for par, but hydroxyproline, acetyl hydroxyproline, etc. are preferably used.
- silicone resin as binder Toray Silicone Co., Ltd. manufactured by Toray Silicone BY22-826; the same shall apply hereinafter
- a cotton plain fabric with a basis weight of 300 gZm 2 was dipped in a solution obtained by diluting the above-mentioned functionality-imparting agent with water so as to be lOOgZL, and then squeezed with a mandala so as to obtain a pickup rate of 100%. And pre-dried. Next, it was heat treated at 170 ° C. for 3 minutes to obtain a nursing sheet. This product has a pressure ulcer prevention effect and is very useful as a nursing sheet.
- a cotton denim woven fabric with a basis weight of 300 gZm 2 was immersed in a solution obtained by diluting the above-described function-imparting agent with water so as to be lOOgZL, and then squeezed with a mandala to obtain a pickup rate of 100%. Pre-dried with C. Next, it was heat treated at 170 ° C. for 3 minutes and sewed onto jeans. This product has a moisturizing and skin-beautifying effect and is very useful as a functional clothing.
- Example 3 N-acetyl-trans-1, 4-hydroxy-1, L-proline, 10 parts of squalane silica microcapsule, 15 parts of ethanol, 10 parts of ethylene oxide of lauryl alcohol, 10 parts of an adduct, 20 parts of silicone resin as a binder, The remainder was made up to 100 parts with water to make a functionality imparting agent for fiber webs.
- Example 3 Instead of N-acetylenotrans 4-hydroxy-L proline in Example 3, the amount of water used was increased to make a total of 100 parts.
- Example 3 The wet tissue obtained in Example 3 and Comparative Example 1 was applied to the elbow part, covered with a nylon film, and stopped with an adhesive tape for upper skin, allowed to stand for 4 hours, and then the skin was removed with a microscope.
- the product of Example 3 showed a skin beautifying effect such as improvement in skin quality
- the product of Comparative Example 1 was powerful without showing a skin beautifying effect.
- the present invention is used in the field of functional fiber products.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Textile Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Professional, Industrial, Or Sporting Protective Garments (AREA)
- Mattresses And Other Support Structures For Chairs And Beds (AREA)
- Bedding Items (AREA)
- Absorbent Articles And Supports Therefor (AREA)
Abstract
Description
明 細 書 Specification
繊維製品への機能性付与剤 Functionality-imparting agent for textile products
技術分野 Technical field
[0001] 本発明は、ヒドロキシプロリンもしくはヒドロキシプロリンの N—ァシル化誘導体又は その塩を含有する、繊維製品に対する機能性付与剤、機能性繊維製品、及び機能 性繊維製品の製造方法に関する。 [0001] The present invention relates to a functional imparting agent for a fiber product, a functional fiber product, and a method for producing the functional fiber product, which contains hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof.
背景技術 Background art
[0002] ヒドロキシプロリンもしくはヒドロキシプロリンの N—ァシル化誘導体又はその塩は、 保湿効果を示すアミノ酸として知られており、化粧料として肌の老化抑制及び肌質改 善等の美肌効果があること (例えば、特許文献 1)、褥瘡の予防、治療効果があること (例えば、特許文献 2)、アトピー性皮膚炎の予防、改善効果があること (例えば、特許 文献 3)、抗炎症、創傷治癒効果があること (例えば、非特許文献 1)が知られている。 [0002] Hydroxyproline, an N-acylated derivative of hydroxyproline, or a salt thereof is known as an amino acid exhibiting a moisturizing effect, and has skin-beautifying effects such as skin aging suppression and skin quality improvement as a cosmetic ( For example, patent document 1), prevention of pressure ulcer, and therapeutic effects (for example, patent document 2), prevention and improvement of atopic dermatitis (for example, patent document 3), anti-inflammatory, wound healing effect (For example, Non-Patent Document 1) is known.
[0003] また、特許文献 4にはアミノ酸類を含有する繊維製品への機能性付与剤が、特許 文献 5には繊維ウェブが開示されているが、該アミノ酸類として、ヒドロキシプロリンも しくはヒドロキシプロリンの N—ァシルイ匕誘導体又はその塩の具体的な記載はな 、。 特許文献 1:国際公開第 OOZ51561号パンフレット [0003] Further, Patent Document 4 discloses an agent for imparting functionality to a fiber product containing amino acids, and Patent Document 5 discloses a fiber web. As the amino acids, hydroxyproline or hydroxy is disclosed. There is no specific description of N-acyl yl derivatives of proline or salts thereof. Patent Document 1: International Publication No. OOZ51561 Pamphlet
特許文献 2 :国際公開第 2004Z28531号パンフレット Patent Document 2: Pamphlet of International Publication No. 2004Z28531
特許文献 3:国際公開第 02Z6225号パンフレット Patent Document 3: International Publication No. 02Z6225 Pamphlet
特許文献 4:特開 2004 - 324026号公報 Patent Document 4: Japanese Patent Application Laid-Open No. 2004-324026
特許文献 5 :国際公開第 96Z31644号パンフレット Patent Document 5: International Publication No. 96Z31644 Pamphlet
非特許文献 1 :ユーロビアン メヂカル リサーチ 3卷、 182— 188頁、 1998年 発明の開示 Non-Patent Document 1: Eurobian Medical Research 3rd, 182-188, 1998 Invention Disclosure
発明が解決しょうとする課題 Problems to be solved by the invention
[0004] 本発明は、ヒドロキシプロリンもしくはヒドロキシプロリンの N—ァシル化誘導体又は その塩の持つ優れた機能を、衣服、寝具、紙ォムッ等に汎用されている繊維基材に 対して、該繊維基材の優れた特性を生カゝしたまま付与することを試みたもので、従来 の繊維の製造工程、特性を大幅に変更することなぐ優れた機能性繊維製品を提供 することを課題とする。 [0004] The present invention relates to an excellent function of hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof for a fiber base material widely used for clothes, bedding, paper omgu, etc. An attempt was made to impart the excellent properties of the wood while keeping it intact, providing superior functional fiber products without drastically changing the conventional fiber manufacturing process and properties. The task is to do.
課題を解決するための手段 Means for solving the problem
[0005] 本発明の要旨は、以下のとおりである。 [0005] The gist of the present invention is as follows.
[0006] (1)ヒドロキシプロリンもしくはヒドロキシプロリンの N—ァシル化誘導体又はその塩を 含有する、繊維製品への機能性付与剤。 [0006] (1) An agent for imparting functionality to a textile product, containing hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof.
[0007] (2)ヒドロキシプロリンの N—ァシル化誘導体が、 N—ァセチル化誘導体、 N—プロピ ォニル化誘導体、 N—プチリル化誘導体又は N—イソプチリル化誘導体である前記 第 1項に記載の機能性付与剤。 [0007] (2) The function according to item 1 above, wherein the N-acylated derivative of hydroxyproline is an N-acetylated derivative, an N-propionylated derivative, an N-propylylated derivative or an N-isoptyrylated derivative. Sex imparting agent.
[0008] (3)マイクロカプセル化、サイクロデキストリンによる包接化、又はべシクル構造体ィ匕さ れて 、る前記第 1又は 2項に記載の機能性付与剤。 [0008] (3) The functional agent according to the above item 1 or 2, which is microencapsulated, encapsulated with a cyclodextrin, or a vesicle structure.
[0009] (4)バインダーを含有する前記第 1〜3項の 、ずれか〖こ記載の機能性付与剤。 [0009] (4) The functionality-imparting agent according to any one of Items 1 to 3, which contains a binder.
[0010] (5)繊維製品を前記第 1〜4項のいずれかに記載の機能性付与剤で処理することを 特徴とする機能性繊維製品の製造方法。 [0010] (5) A method for producing a functional fiber product, wherein the fiber product is treated with the functionality-imparting agent according to any one of Items 1 to 4.
[0011] (6)ヒドロキシプロリンもしくはヒドロキシプロリンの N—ァシル化誘導体又はその塩が 結合されている建装 ·寝装材及び製品、インテリア材及び製品、自動車内装材及び 製品、並びに介護用材料及び製品。 [6] (6) Construction / bedding materials and products, interior materials and products, automobile interior materials and products, and caring materials and materials to which hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof is bound Product.
[0012] (7)ヒドロキシプロリンの N—ァシル化誘導体力 N—ァセチル化誘導体、 N—プロピ ォニル化誘導体、 N—プチリル化誘導体又は N—イソプチリル化誘導体である前記 第 6項に記載の建装 ·寝装材及び製品、インテリア材及び製品、自動車内装材及び 製品、並びに介護用材料及び製品。 [0012] (7) N-acylated derivative power of hydroxyproline N-acetylated derivative, N-propionylated derivative, N-propylylated derivative or N-isoptyrylated derivative according to item 6 above · Bedding materials and products, interior materials and products, automotive interior materials and products, and nursing materials and products.
[0013] (8)ヒドロキシプロリンもしくはヒドロキシプロリンの N—ァシル化誘導体又はその塩が 結合されている衣類。 [0013] (8) A garment to which hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof is bound.
[0014] (9)ヒドロキシプロリンの N—ァシル化誘導体が、 N—ァセチル化誘導体、 N—プロピ ォニル化誘導体、 N—プチリル化誘導体又は N—イソプチリル化誘導体である前記 第 8項に記載の衣類。 [9] The garment according to [8], wherein the N-acylated derivative of hydroxyproline is an N-acetylated derivative, an N-propionylated derivative, an N-propylylated derivative or an N-isoptyrylated derivative. .
[0015] (10)ヒドロキシプロリンもしくはヒドロキシプロリンの N—ァシル化誘導体又はその塩 が結合されている布ォムッ、紙ォムッ、ウエットティッシュ及びティッシュペーパー。 [0015] (10) Cloth, paper, wet tissue and tissue paper to which hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof is bound.
[0016] (11)ヒドロキシプロリンの N—ァシル化誘導体力 N—ァセチル化誘導体、 N—プロ ピオ二ルイヒ誘導体、 N ブチリルイヒ誘導体又は N イソブチリルイヒ誘導体である前 記第 10項に記載の布ォムッ、紙ォムッ、ウエットティッシュ及びティッシュペーパー。 発明の効果 [11] (11) N-acylated derivative power of hydroxyproline N-acetylated derivative, N-pro 11. The cloth, paper, wet tissue and tissue paper according to item 10 above, which is a pionilouich derivative, an N-butyrrhich derivative or an N-isobutyrych derivative. The invention's effect
[0017] 本発明によれば、繊維製品に、保湿性、肌の老化抑制及び肌質改善等の美肌効 果、褥瘡防止性、抗アトピー性、抗炎症性、創傷治癒効果等の機能性を付与するこ とがでさる。 [0017] According to the present invention, the fiber product has functions such as moisture retention, skin aging prevention, skin quality improvement and other skin beautifying effects, pressure ulcer prevention, anti-atopic, anti-inflammatory and wound healing effects. It can be granted.
発明を実施するための最良の形態 BEST MODE FOR CARRYING OUT THE INVENTION
[0018] 本発明で用いられるヒドロキシプロリンは、いずれのヒドロキシプロリンの立体異性体 であってもよい。すなわち、ヒドロキシプロリンのプロリンが D体力 L体力 また水酸基 の位置が 3位か 4位力、及びその立体異性体がシス力トランスかによつて 8種類の立 体異性体があるが、これらの化合物及びそれらの混合物の ヽずれも本発明に用いる ことができる。 [0018] The hydroxyproline used in the present invention may be any stereoisomer of hydroxyproline. In other words, proline of hydroxyproline has 8 physical isomers depending on whether it is D-strength L-strength or hydroxyl-position 3 or 4-position, and its stereoisomer is cis-force trans. And deviations of mixtures thereof can also be used in the present invention.
[0019] 具体的なヒドロキシプロリンとしては、シス一 4 ヒドロキシ一 L—プロリン、シス一 4— ヒドロキシ D—プロリン、シスー3—ヒドロキシ L—プロリン、シスー3—ヒドロキシー D—プロリン、トランスー4ーヒドロキシ L—プロリン、トランスー4ーヒドロキシー D— プロリン、トランス一 3—ヒドロキシ -L-プロリン及びトランス 3—ヒドロキシ D プ 口リンがあげられる。 [0019] Specific examples of hydroxyproline include cis-4-hydroxy-1-L-proline, cis-1-hydroxy-D-proline, cis-3-hydroxy-L-proline, cis-3-hydroxy-D-proline, trans-4-hydroxy-L-- Examples include proline, trans-4-hydroxy-D-proline, trans-1-hydroxy-L-proline, and trans-3-hydroxy-D phosphorus.
[0020] ヒドロキシプロリンは、コラーゲン中の主要構成アミノ酸成分として、また、エラスチン の構成アミノ酸として自然界に広く存在するアミノ酸の一種であり、例えばブタゃゥシ 等の動物由来のコラーゲンを酸加水分解し、常法により精製することにより製造する ことができる。 [0020] Hydroxyproline is a kind of amino acid that exists widely in nature as a major constituent amino acid component in collagen and as a constituent amino acid of elastin. For example, hydroxyproline acid-hydrolyzes collagen derived from animals such as butterfly. It can be produced by purification by a conventional method.
[0021] トランスー4ーヒドロキシ L—プロリンは、アミコラトプシス (Amvcolatopsis)属又はダ クチロスポランジゥム (Dactvlosporangium)属微生物より単離したプロリン 4位水酸化 酵素 (特開平 7— 313179号公報)を用いて製造することができる。また、シス— 3 ヒ ドロキシー L プロリンは、ストレプトマイセス(StreDtomvces)属微牛.物より単離したプ 口リン 3位水酸化酵素(特開平 7— 322885号公報)を用いて製造することができる( バイオインダストリ一, 14卷, 31号, 1997年)。 [0021] Trans-4-hydroxy L-proline is a proline 4-hydroxylase isolated from microorganisms of the genus Amvcolatopsis or Dactvlosporangium (JP-A-7-313179). Can be used. In addition, cis-3 hydroxyl L proline can be produced using porphyrin 3-position hydroxylase (Japanese Patent Laid-Open No. 7-322885) isolated from Streptomyces genus cattle. Yes, Bioindustry 1, 14 卷, 31 (1997).
[0022] 前記の微生物由来の酵素を用いて製造されるヒドロキシプロリンは、品質が優れて おり、本発明で用いるヒドロキシプロリンとしてより好ましい。 [0022] Hydroxyproline produced using the above-mentioned microorganism-derived enzyme has excellent quality. It is more preferable as hydroxyproline used in the present invention.
[0023] 本発明で用いられるヒドロキシプロリンの N—ァシルイ匕誘導体としては、前記の各種 ヒドロキシプロリンの立体異性体の N—ァシルイ匕誘導体をあげることができる。該 N— ァシルイ匕誘導体のァシル基としては、好ましくは炭素数 1〜24、より好ましくは炭素数 1〜12、特に好ましくは炭素数 1〜6のァシル基があげられ、具体的には、例えばホ ノレミノレ、ァセチノレ、プロピオニル、ブチリノレ、イソブチリル、ノ レリノレ、ピバロィル、へキ サノィル、ヘプタノィル、オタタノィル、ノナノィル、デカノィル、ゥンデカノィル、ドデカ ノィル等をあげることができ、特にァセチル、プロピオニル、ブチリル、イソブチリルが 好ましい。 [0023] Examples of the N-acyl yl derivatives of hydroxyproline used in the present invention include the above-mentioned N-acyl yl derivatives of the various hydroxyproline stereoisomers. Examples of the acyl group of the N-acyl derivative include preferably an acyl group having 1 to 24 carbon atoms, more preferably 1 to 12 carbon atoms, and particularly preferably 1 to 6 carbon atoms. Honoleminole, acetinole, propionyl, butyrinole, isobutyryl, norellinore, pivalol, hexanol, heptanol, otatanyl, nonanoyl, decanol, undecanol, dodecanol, etc.
[0024] ヒドロキシプロリンもしくはヒドロキシプロリンの N—ァシル化誘導体の塩としては、ナ トリウム、カリウム、リチウム等のアルカリ金属塩、カルシウム、マグネシウム等のアル力 リ土類金属塩、アンモ-ゥム塩、モノエタノールァミン、ジエタノールァミン、トリェタノ ールァミン、トリイソプロパノールァミンなどのァミンの付加塩及びアルギニン、リジン 等の塩基性アミノ酸の付加塩などをあげることができる。 [0024] Examples of the salt of hydroxyproline or N-acylated derivative of hydroxyproline include alkali metal salts such as sodium, potassium and lithium, alkaline earth metal salts such as calcium and magnesium, ammonium salts, Examples thereof include addition salts of amines such as monoethanolamine, diethanolamine, triethanolamine and triisopropanolamine, and addition salts of basic amino acids such as arginine and lysine.
[0025] ヒドロキシプロリンの N—ァシルイ匕誘導体は、公知の方法により調製することができ る。例えば、ヒドロキシプロリンの N—ァシルイ匕誘導体は、直鎖又は分岐状の炭素数 1 〜24の飽和又は不飽和の脂肪酸を塩ィ匕チォ -ル、ホスゲン等のハロゲン化剤を用 いてクロライド、ブロマイド等のハロゲンィ匕物に変換した後、前述のヒドロキシプロリン と縮合させるか、又は脂肪酸を酸無水物に変換した後、ヒドロキシプロリンと反応させ ること〖こより製造することができる。 [0025] The N-acyl derivative of hydroxyproline can be prepared by a known method. For example, N-acyl derivatives of hydroxyproline are linear or branched saturated fatty acids having 1 to 24 carbon atoms, such as chlorides and bromides using halogenating agents such as salt and phosgene. The product can be produced by conversion to a halogenated product such as the above, followed by condensation with hydroxyproline as described above, or conversion of a fatty acid to an acid anhydride followed by reaction with hydroxyproline.
[0026] 脂肪酸としては、例えばギ酸、酢酸、プロピオン酸、酪酸、イソ酪酸、吉草酸、イソ吉 草酸、ピバル酸、へキサン酸、ヘプタン酸、オクタン酸、ノナン酸、デカン酸、ゥンデ力 ン酸、ドデカン酸等の脂肪酸を単独又は組合せたものが用いられる。 [0026] Examples of fatty acids include formic acid, acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, pivalic acid, hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, and undehydroacid. A fatty acid such as dodecanoic acid is used alone or in combination.
[0027] 酸ハロゲン化物を経由するヒドロキシプロリンの N—ァシル化誘導体の製造方法を 、以下に例示する。 [0027] A method for producing an N-acylated derivative of hydroxyproline via an acid halide is exemplified below.
[0028] 脂肪酸を塩化メチレン、クロ口ホルム、四塩化炭素、ベンゼン、トルエン、キシレン、 n—へキサン等の溶媒中に分散し、これに 1〜5倍当量のハロゲン化剤を添加して反 応させ、脂肪酸ノヽライドを得る。次に、ヒドロキシプロリンを溶媒に溶解又は分散させ、 得られた溶液を 5〜70°Cに保ちながら、前記の脂肪酸ノヽライドをヒドロキシプロリンに 対して 0. 3〜3. 0倍当量加え、ァシル化反応を行うことによりヒドロキシプロリンの N ーァシルイ匕誘導体を製造することができる。 [0028] The fatty acid is dispersed in a solvent such as methylene chloride, chloroform, carbon tetrachloride, benzene, toluene, xylene, n-hexane, etc., and 1 to 5 times equivalent of a halogenating agent is added thereto to react. To obtain a fatty acid noride. Next, hydroxyproline is dissolved or dispersed in a solvent, While maintaining the obtained solution at 5 to 70 ° C., 0.3 to 3.0 times equivalent of the above fatty acid halide to hydroxyproline was added, and an acylation reaction was carried out, whereby an N-acylyde derivative of hydroxyproline. Can be manufactured.
[0029] ァシルイ匕反応に用いられる溶媒としては、水、メタノール、エタノール、イソプロパノ ール、イソブタノール、アセトン、トルエン、テトラヒドロフラン、酢酸ェチル、 N, N ジ メチルホルムアミド、ジメチルスルホキシド等があげられ、これらは単独又は混合して 用いてもよい。ヒドロキシプロリンを溶媒に溶解又は分散する際、ヒドロキシプロリンに 対して 0. 8〜2. 0倍当量の水酸ィ匕ナトリウム、水酸ィ匕カリウム等のアルカリ物質を必 要に応じて溶媒に溶解又は分散させてもよい。 [0029] Examples of the solvent used in the acyl chloride reaction include water, methanol, ethanol, isopropanol, isobutanol, acetone, toluene, tetrahydrofuran, ethyl acetate, N, N dimethylformamide, dimethyl sulfoxide, and the like. May be used alone or in combination. When hydroxyproline is dissolved or dispersed in a solvent, 0.8 to 2.0 times equivalent of alkaline substance such as sodium hydroxide and potassium hydroxide is dissolved in the solvent as necessary. Alternatively, it may be dispersed.
[0030] ヒドロキシプロリンの N ァシル化誘導体の塩を取得したいとき、ヒドロキシプロリン の N ァシルイ匕誘導体が塩の形で得られる場合には、そのまま精製すればよぐ遊 離の形で得られる場合には、適当な溶媒に溶解又は懸濁し、塩基を加えて塩を形成 させればよい。 [0030] When it is desired to obtain a salt of an N-acylated derivative of hydroxyproline, if the N-acylated derivative of hydroxyproline is obtained in the form of a salt, it can be purified as it is and obtained in a free form. May be dissolved or suspended in a suitable solvent and a base may be added to form a salt.
[0031] 精製は、例えば結晶ィ匕、クロマトグラフィー等の通常の方法が用いられる。 [0031] For purification, for example, usual methods such as crystallizing and chromatography are used.
[0032] 具体的なヒドロキシプロリンの N ァシル化誘導体としては、例えば、 N—ァセチル —シス一 4—ヒドロキシ一 L—プロリン、 N—ァセチノレ一シス一 4—ヒドロキシ一 D—プ 口リン、 N—ァセチルーシス一 3—ヒドロキシ一 L—プロリン、 N ァセチルーシス一 3 -ヒドロキシ D プロリン、 N ァセチノレ一トランス一 4—ヒドロキシ L プロリン、 N ァセチノレ トランス 4 ヒドロキシ D—プロリン、 N ァセチノレ トランス 3 -ヒドロキシ L プロリン、 N ァセチノレ -トランス 3—ヒドロキシ D プロリン、 N -プロピオニル -シス 4—ヒドロキシ -L-プロリン、 N -プロピオニル -シス - 4 -ヒドロキシ -D-プロリン、 N -プロピオニル -シス 3—ヒドロキシ L プロリン、 N プロピオニル シス 3—ヒドロキシ D—プロリン、 N プロピオニル トランス 4ーヒドロキシ L—プロリン、 N—プロピオニノレートランスー4ーヒドロキシ D プ 口リン、 N—プロピオニノレートランスー3—ヒドロキシ L—プロリン、 N—プロピオ二ノレ トランス 3—ヒドロキシ D—プロリン、 N ブチリノレーシスー4ーヒドロキシー L プロリン、 N ブチリルーシスー4ーヒドロキシ—D—プロリン、 N ブチリルーシス 3 ーヒドロキシ L—プロリン、 N ブチリルーシスー3—ヒドロキシ D—プロリン、 N— ブチリノレ トランス 4 ヒドロキシ L—プロリン、 N ブチリノレ トランス 4ーヒドロ キシ D—プロリン、 N ブチリルートランスー3—ヒドロキシ L—プロリン、 N ブチ リル一トランス一 3—ヒドロキシ一 D プロリン、 N—イソブチリル一シス一 4—ヒドロキ シ L—プロリン、 N—イソブチリルーシスー4ーヒドロキシ D—プロリン、 N—イソブ チリル一シス一 3—ヒドロキシ L プロリン、 N イソブチリル一シス一 3—ヒドロキシ —D—プロリン、 N—イソブチリノレートランスー4ーヒドロキシ L—プロリン、 N—イソ ブチリル一トランス一 4—ヒドロキシ D プロリン、 N イソブチリル一トランス一 3—ヒ ドロキシ一 L プロリン、 N—イソブチリル一トランス一 3—ヒドロキシ一 D プロリン等 をあげることができる。 [0032] Specific N-acylated derivatives of hydroxyproline include, for example, N-acetyl-cis-4-hydroxy-1-L-proline, N-acetylenolysis-1-4-hydroxy-1-D-proline, N- 1-hydroxyl L-proline, N-acetylenic 1-hydroxy D-proline, N-acetylenic trans 4-4-hydroxy L-proline, N-acetylin trans 4-hydroxy D-proline, N-acetylinole trans 3-hydroxyl-proline, N-acetylinole -Trans 3-hydroxy D proline, N-propionyl-cis 4-hydroxy-L-proline, N-propionyl-cis-4-hydroxy-D-proline, N-propionyl-cis 3-hydroxy L proline, N propionyl cis 3 —Hydroxy D—proline, N propionyl trans 4-hydroxy L— Proline, N-propioninoletrans 4-hydroxy D pulin, N-propioninole trans 3-hydroxy L-proline, N-propioninole trans 3-hydroxy D-proline, N butyrinolesis 4-hydroxy L proline, N butyryl cis-4-hydroxy-D-proline, N butyryl lucose 3-hydroxy L-proline, N butyryl cis 3-hydroxy D-proline, N— Butyrinore trans 4 Hydroxy L—proline, N Butyrinore trans 4—Hydroxy D—Proline, N Butyryl ro trans 3—Hydroxy L—Proline, N Butylyl 1 trans 1—Hydroxy 1 D Proline, N—Isobutyryl 1 cis 1 4 —Hydroxy L-proline, N-isobutyryl cis-4-hydroxy D-proline, N-isobutyryl cis 1 3-hydroxy L proline, N isobutyryl cis 1 3-hydroxy —D-proline, N-isobutyrino Rhettrans-4-hydroxy L-proline, N-isobutyryl 1-trans 4-hydroxy D proline, N-isobutyryl 1-trans 1-hydroxy 1-L proline, N-isobutyryl 1-trans 1 3-hydroxy 1-D proline, etc. be able to.
[0033] 本発明の機能性付与剤は、ヒドロキシプロリンもしくはヒドロキシプロリンの N—ァシ ル化誘導体又はその塩を 0. 01〜30重量%含有することが好ましい。 [0033] The function-imparting agent of the present invention preferably contains 0.01 to 30% by weight of hydroxyproline, a hydroxyproline N-acylated derivative or a salt thereof.
[0034] 本発明の機能性付与剤は、例えば、ヒドロキシプロリンもしくはヒドロキシプロリンの N ァシル化誘導体又はその塩 0. 01〜30重量部〖こ、必要〖こよりソルビトール、ソル ビット等の安定化剤を 0. 1〜10重量部、例えば、 5 クロ口 2—メチル—4—イソチ ァゾリン一 3 オンと 2 メチル 4 イソチアゾリン一 3 オンの複合製剤(商品名: ケーソン)等のイソチアゾリン系抗菌剤等の防腐剤を 0. 05-0. 3重量部、バインダ 一を 0. 5〜25重量部、更に水を全量が 100重量部となるようにカ卩えて製造する。 [0034] The functionality-imparting agent of the present invention includes, for example, a stabilizer such as hydroxyproline or a N-calyzed derivative of hydroxyproline or a salt thereof of 0.01 to 30 parts by weight, necessary sorbitol or sorbitol. 0.1 to 10 parts by weight, for example, antiseptic of isothiazoline-based antibacterial agents such as 5-clonal 2-methyl-4-isothiazolin-1-one and 2-methyl-4-isothiazolin-1-one compound (trade name: caisson) Preparation is made with 0.05 to 0. 3 parts by weight of the agent, 0.5 to 25 parts by weight of the binder, and 100 parts by weight of water.
[0035] 本発明の機能性付与剤には、更に、ペプチド、ヒドロキシプロリンもしくはヒドロキシ プロリンの N ァシルイ匕誘導体又はその塩以外のアミノ酸類、ビタミン類、セラミド、甘 草エキスのグリチルリチン酸類、ラズベリー類のエキス、ラベンダーエキス、ジャスミン エキス、ぺノ 一ミントエキス、ローズマリーエキス、ローマン力モミ一ノレエキス、ユーカリ エキス、ヒノキチオール、竹エキス、アロエエキス、カテキン、グレープフノレーツエキス 、レモンエキス、ホホバ油、ォリーブ油、柑橘油、海藻エキス、スクヮラン類、コラーゲ ン及びブドウ糖類力もなる群力 選ばれる少なくとも一種を組み合わせてもよい。 [0035] The functionality-imparting agent of the present invention further includes peptides, hydroxyproline or amino acid derivatives other than salts of hydroxyproline or its salts, vitamins, ceramides, glycyrrhizic acids of licorice extract, and raspberries. Extract, lavender extract, jasmine extract, peno mint extract, rosemary extract, roman force fir mono extract, eucalyptus extract, hinokitiol, bamboo extract, aloe extract, catechin, grape funoles extract, lemon extract, jojoba oil, olive oil Citrus oil, seaweed extract, squalene, collagen, and at least one selected from the group power that also has glucose strength may be combined.
[0036] 前記ペプチドとしては、シルクプロテイン、フイブ口イン等が挙げられ、前記アミノ酸 類としては、グルタミン酸、ァスパラギン酸、グリシン、シスチン、セリン、ヒスチジン、リ ジン、アルギニン、ロイシン等が挙げられる力 これらに限られるものではない。前記 ビタミン類としては、ビタミン A、ビタミン C、ビタミン E等が効果的に使用でき、甘草ェ キスの前記グリチルリチン酸類としては、グリチルリチン酸、グリチルレチン酸、グリチ ルリチン酸ナトリウム、グリチルリチン酸カリウム、グリチルリチン酸アンモ-ゥム等が挙 げられる。更に、前記ラズベリー類としては、ラズベリー、ラズベリーケトン等が挙げら れ、前記スクヮラン類としては、スクヮラン、スクワレン等が挙げられ、前記ブドウ糖類と しては、ブドウ糖、キシリトール、エリスリトール等が挙げられる。更に、キチン、キトサ ン等の抗菌剤を組み合わせてもよい。中でも、シルクプロテイン、フイブ口イン、スクヮ ラン等との組み合わせ力 S、衣類などにした場合に非常に特徴のあるソフトでボリユー ム感のある風合が得られるので、特に好ましい。 [0036] Examples of the peptide include silk protein, hive mouth-in, and the like, and examples of the amino acids include glutamic acid, aspartic acid, glycine, cystine, serine, histidine, lysine, arginine, leucine and the like. It is not limited to. As the vitamins, vitamin A, vitamin C, vitamin E, etc. can be used effectively. Examples of the glycyrrhizic acid of Kiss include glycyrrhizic acid, glycyrrhetinic acid, sodium glycyrrhizinate, potassium glycyrrhizinate, and ammonium glycyrrhizinate. Furthermore, examples of the raspberries include raspberries and raspberry ketones, examples of the squalans include squalans and squalene, and examples of the glucose include glucose, xylitol, and erythritol. Furthermore, antibacterial agents such as chitin and chitosan may be combined. Among them, the combination strength S with silk protein, hive mouth-in, screen lantern, and the like, clothing, etc. is particularly preferable because a very characteristic soft and volumey texture can be obtained.
[0037] 本発明の機能性付与剤において、ヒドロキシプロリンもしくはヒドロキシプロリンの N —ァシルイ匕誘導体又はその塩等の成分は、通常の状態のまま使用してもよいが、マ イク口カプセル化、サイクロデキストリンによる包接ィ匕又はべシクル構造体ィ匕して使用 してもよく、この場合、油性はもちろん、親水性の化合物でも繊維類や、不織布、繊 維ウェブに洗濯耐久性よく付与することが可能となり、特にバインダーの使用により 洗濯耐久性の向上が可能となる。前記べシクル構造体は、特定の濃度において、分 子重合体を形成する界面活性剤を利用するもので、界面活性剤分子集合体すなわ ちべシクル袋状 2分子膜は、内部に水相と油相を有する。その油相に、油性の化合 物等をべンジルベンゾエート等の溶剤に溶解し、べシクル構造体の油相部へ保持さ せる。 [0037] In the functionality-imparting agent of the present invention, components such as hydroxyproline or a hydroxyproline N-acyl yl derivative or a salt thereof may be used in a normal state. It may be used as a clathrate or vesicle structure with dextrin. In this case, not only oiliness but also hydrophilic compounds should be applied to fibers, nonwoven fabrics and fiber webs with good washing durability. In particular, the durability of washing can be improved by using a binder. The vesicle structure utilizes a surfactant that forms a polymer at a specific concentration. The surfactant molecule aggregate, that is, the vesicle bag-like bilayer membrane, has an aqueous phase inside. And has an oil phase. In the oil phase, an oily compound or the like is dissolved in a solvent such as benzyl benzoate and held in the oil phase portion of the vesicle structure.
[0038] 本発明の機能性付与剤は、バインダーを含有する場合には、そのまま繊維製品に 固着させることが可能であり、またバインダーを含有しない場合には、別途バインダー を使用して固着させることができる。前記バインダーとしては、アクリル酸エステル系、 例えば大原パラヂゥム化学株式会社製のパラレジン GH— S、ウレタン系バインダー 、例えば大原パラヂゥム化学株式会社製のパラゾール PN— 20、シリコーン系バイン ダー、例えば東レシリコーン株式会社製のトーレ'シリコーン BY22— 826、その他、 フッ素系、エポキシ系などのポリマーを使用するのが好ましい。なお、バインダーの使 用量は、ヒドロキシプロリンもしくはヒドロキシプロリンの N—ァシル化誘導体又はその 塩 0. 01〜30重量部に対して、好ましくは 0. 5〜25重量部である。 [0038] When the functionality-imparting agent of the present invention contains a binder, it can be fixed to a fiber product as it is, and when it does not contain a binder, it can be fixed using a separate binder. Can do. Examples of the binder include acrylic ester-based, for example, Pararesin GH-S manufactured by Ohara Paradum Chemical Co., Ltd., urethane-based binders, for example, Parasol PN-20 manufactured by Ohara Paradum Chemical Co., Ltd., silicone binders such as Toray Silicone Co., Ltd. It is preferable to use Toray Silicone BY22-826 made by the company and other polymers such as fluorine and epoxy. The amount of the binder used is preferably 0.5 to 25 parts by weight relative to 0.01 to 30 parts by weight of hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof.
[0039] なお、本発明では、かかる機能性付与剤を繊維製品に固着させ、繊維製品に、保 湿性、肌の老化抑制及び肌質改善等の美肌効果、抗アトピー、抗炎症、創傷治癒効 果、褥瘡防止性などの機能性を付与することができるが、この際、機能性付与剤は、 バインダーを含む処理液とし、繊維製品にデイツビング、パディング、コーティング、ス プレー加工等の公知の方法で付着させ、乾燥固着すればよ!、。 [0039] It should be noted that in the present invention, such a functionality-imparting agent is fixed to a fiber product, and the fiber product is retained. Functionality such as moisture, skin aging control and skin improvement, anti-atopy, anti-inflammatory, wound healing effect, pressure ulcer prevention, etc. can be added. Use a treatment solution containing a binder, attach it to textiles using a known method such as dubbing, padding, coating, spraying, etc., and fix it dry!
[0040] 処理される繊維製品は、糸、織物、編物、不織布、繊維ウェブ等の 、ずれの形状で もよぐ繊維の種類も、特に限定されない。繊維製品への、機能性付与剤の付着量は 、特に限定されないが、固形分で通常 0. 05〜5重量%程度、好ましくは 1〜3重量 %である。 [0040] The fiber product to be treated is not particularly limited in terms of the type of fiber, such as yarn, woven fabric, knitted fabric, non-woven fabric, and fiber web, which may be misaligned. The adhesion amount of the function-imparting agent to the fiber product is not particularly limited, but is usually about 0.05 to 5% by weight, preferably 1 to 3% by weight in terms of solid content.
[0041] 本発明の建装'寝装材及び製品、インテリア材及び製品、 自動車内装材及び製品 、介護用材料及び製品とは、ヒドロキシプロリンもしくはヒドロキシプロリンの N—ァシ ル化誘導体又はその塩を木綿 ιοο%、木綿 Zポリエステル混紡品、麻 Zポリエステ ル混紡品等の繊維に結合させた、布団生地、毛布、シーツ、イス用生地、カーペット 、カーシート用生地、シートカバー等を示し、これらの用品に用いるヒドロキシプロリン もしくはヒドロキシプロリンの N—ァシル化誘導体又はその塩はどのようなものでもよい 力 ヒドロキシプロリン、ァセチルヒドロキシプロリン等を用いることが好ましい。 [0041] The building materials of the present invention 'bedding materials and products, interior materials and products, automotive interior materials and products, care materials and products are hydroxyproline, N-acylated derivatives of hydroxyproline or salts thereof Indicates fabric, blanket, sheets, chair fabric, carpet, car seat fabric, seat cover, etc., which are bonded to fibers such as cotton ιοο%, cotton Z polyester blend, hemp Z polyester blend, etc. Any of the hydroxyproline, the N-acylated derivative of hydroxyproline or a salt thereof may be used in the article. It is preferable to use hydroxyproline, acetyl hydroxyproline and the like.
[0042] 本発明の衣類とは、ヒドロキシプロリンもしくはヒドロキシプロリンの N—ァシル化誘導 体又はその塩を木綿 100%、ポリエステル 100%、木綿 Zポリエステル混品、ナイ口 ン 100%、木綿 Zナイロン混品等の繊維に結合させた肌着、パンティーストッキング、 タイツ、シャツ、ブラウス、カジュアルウエア、ジーンズ、パンツ等の衣類を示し、当該 衣類に用いるヒドロキシプロリンもしくはヒドロキシプロリンの N—ァシルイ匕誘導体又は その塩はどのようなものでもよいが、ヒドロキシプロリン、ァセチルヒドロキシプロリン等 を用いることが好ましい。 [0042] The garment of the present invention is hydroxyproline or a hydroxyproline N-acylation derivative or a salt thereof made of 100% cotton, 100% polyester, cotton Z polyester blend, 100% nylon, cotton Z nylon blend. This refers to clothing such as underwear, pantyhose, tights, shirts, blouses, casual wear, jeans, pants, etc. bonded to textiles, etc., and hydroxyproline or N-acyl 匕 derivative of hydroxyproline used in the clothing or its salt is Any of them may be used, but it is preferable to use hydroxyproline, acetyl hydroxyproline, or the like.
[0043] 本発明の布ォムッ、紙ォムッ、ウエットティッシュ、ティッシュペーパーとは、ヒドロキ シプロリンもしくはヒドロキシプロリンの N—ァシル化誘導体又はその塩を、布ォムッに 関しては木綿、紙ォムッに関しては通常用いられる吸水性榭脂(特開平 9— 157543 号参照)、ウエットティッシュに関しては紙に結合させて製品化したものを示す。また、 安全性の高い天然物力 なる抗菌剤、消臭剤や、銀コロイド等の抗菌剤、消臭剤等 との併用使用でもよい。当該布ォムッ、紙ォムッ、ウエットティッシュ、ティッシュぺー パーに用いられるヒドロキシプロリンもしくはヒドロキシプロリンの N ァシル化誘導体 又はその塩はどのようなものでもよいが、ヒドロキシプロリン、ァセチルヒドロキシプロリ ン等を用いることが好ましい。 [0043] The cloth ommu, paper ommu, wet tissue, and tissue paper of the present invention use hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof, and cotton woven paper and paper ommu are usually used for the cloth ommu. The water-absorbent fats and oils (see Japanese Patent Application Laid-Open No. 9-157543) and the wet tissue are those produced by bonding to paper. It may also be used in combination with antibacterial agents and deodorizers that are highly safe and natural products, antibacterial agents such as silver colloids, and deodorants. Cloth, paper, wet tissue, tissue paper Any hydroxyproline or hydroxyproline N-acylated derivative or salt thereof may be used for par, but hydroxyproline, acetyl hydroxyproline, etc. are preferably used.
[0044] 本明細書は、本願の優先権の基礎である特願 2005— 134124の明細書に記載さ れた内容を包含する。 [0044] This specification includes the contents described in the specification of Japanese Patent Application No. 2005-134124, which is the basis of the priority of the present application.
実施例 Example
[0045] 次に、本発明の実施例を示すが、実施例において部とあるのは、特に断らない限り [0045] Next, examples of the present invention will be described. In the examples, the term "parts" is used unless otherwise specified.
、重量部を示す。 Indicates parts by weight.
[0046] 〔実施例 1〕 [Example 1]
N—ァセチルートランスー4ーヒドロキシ—L—プロリン 20部、グリチルリチン酸アン モ -ゥム 20部、エタノール 5部、ラウリルアルコールのエチレンオキサイド 10モル付カロ 物 10部、バインダーとしてシリコーン系榭脂 (東レシリコーン株式会社製トーレ'シリコ ーン BY22— 826 ;以下同様)を 20部、残りを水で全量 100部とし、繊維布帛用機能 性付与剤とした。 N-acetyl-trans-4-hydroxy-L-proline 20 parts, ammonium glycyrrhizinate 20 parts, ethanol 5 parts, lauryl alcohol ethylene oxide 10 parts calories 10 parts, silicone resin as binder ( Toray Silicone Co., Ltd. manufactured by Toray Silicone BY22-826; the same shall apply hereinafter) was made into 20 parts, and the remainder was made up to 100 parts in total with water to give a functional additive for fiber fabrics.
[0047] 次に目付が 300gZm2の木綿平織物を、前記機能性付与剤を lOOgZLとなるよう に水で希釈した液に浸漬後、ピックアップ率 100%となるようにマンダルで絞り、 100 °Cで予備乾燥した。次いで、 170°Cで 3分間熱処理して介護用シーツとした。この製 品は、褥瘡予防効果があり、介護用シーツとして非常に有用なものとなった。 [0047] Next, a cotton plain fabric with a basis weight of 300 gZm 2 was dipped in a solution obtained by diluting the above-mentioned functionality-imparting agent with water so as to be lOOgZL, and then squeezed with a mandala so as to obtain a pickup rate of 100%. And pre-dried. Next, it was heat treated at 170 ° C. for 3 minutes to obtain a nursing sheet. This product has a pressure ulcer prevention effect and is very useful as a nursing sheet.
[0048] 〔実施例 2〕 [Example 2]
トランス 4 ヒドロキシ L プロリン 20部、グリチルリチン酸アンモ-ゥム 20部、 エタノール 5部、トリデシルアルコールのエチレンオキサイド 10モル付カ卩物 10部、ノ インダーとしてシリコーン系榭脂を 20部、残りを水で全量 100部とし、繊維布帛用機 能性付与剤とした。 20 parts of trans 4 hydroxy L proline, 20 parts of ammonium glycyrrhizinate, 5 parts of ethanol, 10 parts of 10 mol of tridecyl alcohol ethylene oxide, 20 parts of silicone resin as a noder, and the remaining water The total amount was 100 parts, and it was used as a functional additive for fiber fabrics.
[0049] 次に目付が 300gZm2の木綿デニム織物を、前記機能性付与剤を lOOgZLとなる ように水で希釈した液に浸漬後、ピックアップ率 100%となるようにマンダルで絞り、 1 00°Cで予備乾燥した。次いで、 170°Cで 3分間熱処理して、ジーンズに縫製した。こ の製品は、保湿、美肌効果があり、機能性衣類として非常に有用なものとなった。 [0049] Next, a cotton denim woven fabric with a basis weight of 300 gZm 2 was immersed in a solution obtained by diluting the above-described function-imparting agent with water so as to be lOOgZL, and then squeezed with a mandala to obtain a pickup rate of 100%. Pre-dried with C. Next, it was heat treated at 170 ° C. for 3 minutes and sewed onto jeans. This product has a moisturizing and skin-beautifying effect and is very useful as a functional clothing.
[0050] 〔実施例 3〕 N ァセチルートランス一 4 ヒドロキシ一 L プロリン 10部、スクヮランのシリカマイ クロカプセル 15部を、エタノール 5部、ラウリルアルコールのエチレンオキサイド 10モ ル付加物 10部、バインダーとしてシリコーン系榭脂を 20部、残りを水で全量 100部と し、繊維ウェブ用機能性付与剤とした。 [Example 3] N-acetyl-trans-1, 4-hydroxy-1, L-proline, 10 parts of squalane silica microcapsule, 15 parts of ethanol, 10 parts of ethylene oxide of lauryl alcohol, 10 parts of an adduct, 20 parts of silicone resin as a binder, The remainder was made up to 100 parts with water to make a functionality imparting agent for fiber webs.
[0051] 次に、前記機能性付与剤を 30gZLに水で薄めた液を、 目付が 25gZm2のウエット ティッシュ用紙(セルロース繊維ウェブ)にキスロールでピックアップが 50%になるよう に付着させた後、ウエットティッシュ製品に成形加工した。 [0051] Next, after a solution obtained by diluting the functionality-imparting agent to 30 gZL with water is attached to a wet tissue paper (cellulose fiber web) having a basis weight of 25 gZm 2 with a kiss roll so that the pickup becomes 50%, Molded into a wet tissue product.
[0052] 〔比較例 1〕 [Comparative Example 1]
実施例 3の N ァセチノレ トランス 4ーヒドロキシー L プロリンを除 、た代わりに 水の使用量を増カロさせて合計 100部とした。 Instead of N-acetylenotrans 4-hydroxy-L proline in Example 3, the amount of water used was increased to make a total of 100 parts.
[0053] 実施例 3と比較例 1で得たウエットティッシュを、肘部分に当て、ナイロンフィルムで カバーし、その上力 皮膚用接着テープで止めて 4時間放置した後、マイクロスコー プで皮膚の状態を拡大観察したところ、実施例 3の製品は肌質改善等の美肌効果を 示すのに対し、比較例 1の製品は、美肌効果を示さな力つた。 [0053] The wet tissue obtained in Example 3 and Comparative Example 1 was applied to the elbow part, covered with a nylon film, and stopped with an adhesive tape for upper skin, allowed to stand for 4 hours, and then the skin was removed with a microscope. When the state was magnified, the product of Example 3 showed a skin beautifying effect such as improvement in skin quality, while the product of Comparative Example 1 was powerful without showing a skin beautifying effect.
[0054] 〔実施例 4〕 [Example 4]
トランス 4ーヒドロキシ L—プロリン 20部、スクヮランとラズベリ一エキスのべシク ル構造体 20部をエタノール 5部、ラウリルアルコールのエチレンオキサイド 10モル付 加物 10部、バインダーとしてシリコーン系榭脂を 20部、残りを水で全量 100部とし、 繊維布帛用機能性付与剤とした。 20 parts of trans 4-hydroxy L-proline, 20 parts of the skeleton structure of squalane and raspberry extract, 5 parts of ethanol, 10 parts of 10 mol of ethylene oxide of lauryl alcohol, 20 parts of silicone-based resin as a binder, The remainder was made up to 100 parts with water to give a functionality-imparting agent for fiber fabrics.
[0055] 次に目付が 200gZm2の繊維ニット(ナイロン 20%、アクリル 50%、ウール 30%力 らなるニット)を、前記機能性付与剤を 150gZLとなるように水で希釈した液に浸漬 後、ピックアップ率 100%となるようにマンダルで絞り、 100°Cで 5分間予備乾燥した。 次いで、 170°Cで 1分間熱処理してエステ用の手足保護カバー具とした。 [0055] Next, after immersing a fiber knit having a basis weight of 200 gZm 2 (knit made of 20% nylon, 50% acrylic, 30% wool) in a solution diluted with water so that the above-mentioned functionality-imparting agent becomes 150 gZL. Then, it was squeezed with a mandal so that the pickup rate was 100%, and pre-dried at 100 ° C for 5 minutes. Next, it was heat-treated at 170 ° C. for 1 minute to obtain a limb protection cover for esthetics.
[0056] 就寝時に、かかる保護カバー具で片方の手足を覆い、他方の手足は保護カバー具 なしで、 1週間経過した後、手足の状態を、マイクロスコープ写真で比較した。その結 果、保護カバー具をした手足は、保護カバーをしな力つた手足に比べ、肌の潤いが 増し、皺が除去された。 [0056] At bedtime, one limb was covered with such a protective cover, and the other limb was without a protective cover, and after one week, the state of the limb was compared with a microscope photograph. As a result, the limbs with protective covers were moisturized and wrinkles were removed compared to limbs with strong protective covers.
[0057] 本明細書中で引用した全ての刊行物、特許及び特許出願をそのまま参考として本 明細書中にとり入れるものとする。 [0057] All publications, patents and patent applications cited in this specification are used as is for reference. It shall be incorporated in the description.
産業上の利用可能性 Industrial applicability
本発明は機能性繊維製品の分野で利用される。 The present invention is used in the field of functional fiber products.
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007528169A JPWO2006120851A1 (en) | 2005-05-02 | 2006-04-19 | Functionality-imparting agent for textile products |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005134124 | 2005-05-02 | ||
| JP2005-134124 | 2005-05-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2006120851A1 true WO2006120851A1 (en) | 2006-11-16 |
Family
ID=37396364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2006/308214 Ceased WO2006120851A1 (en) | 2005-05-02 | 2006-04-19 | Agent for imparting functions to textile products |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2006120851A1 (en) |
| WO (1) | WO2006120851A1 (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008126782A1 (en) * | 2007-04-06 | 2008-10-23 | Kyowa Hakko Bio Co., Ltd. | Antiseptic agent for skin |
| JP2009270208A (en) * | 2008-05-01 | 2009-11-19 | Ohara Palladium Kagaku Kk | Antibacterial deodorant processing agent for fiber and textile product processed with the processing agent |
| US8338404B2 (en) * | 2007-09-11 | 2012-12-25 | Kyowa Hakko Bio Co., Ltd. | Composition and method for reducing allergen |
| ITVR20120104A1 (en) * | 2012-05-22 | 2013-11-23 | Paolo Srl O | PROCESS OF TREATMENT OF FABRICS INTENDED TO GO TO CONTACT WITH THE HUMAN BODY |
| WO2014007290A1 (en) * | 2012-07-03 | 2014-01-09 | 味の素株式会社 | Moisturizer and cosmetic containing same |
| JP2018202170A (en) * | 2017-06-02 | 2018-12-27 | 三洋化成工業株式会社 | Absorbent article |
| JP2018202165A (en) * | 2017-06-02 | 2018-12-27 | 三洋化成工業株式会社 | Absorbent articles |
| WO2019012744A1 (en) | 2017-07-14 | 2019-01-17 | 信越化学工業株式会社 | Functional-agent-containing fiber and method for manufacturing same |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5598978A (en) * | 1979-01-18 | 1980-07-28 | Keizou Ogino | Dyeing of polyamide product |
| JPS58212447A (en) * | 1982-05-26 | 1983-12-10 | シ−トン・カンパニ− | Production of coagulable porous collagen sheet material |
| JPS62110977A (en) * | 1985-11-11 | 1987-05-22 | 日本油脂株式会社 | Pearl like softener composition |
| JP2000178881A (en) * | 1998-12-15 | 2000-06-27 | Fuji Spinning Co Ltd | Processing method of cellulosic fabric |
| WO2000051561A1 (en) * | 1999-03-02 | 2000-09-08 | Kyowa Hakko Kogyo Co., Ltd. | Cosmetics |
| WO2003018073A2 (en) * | 2001-08-24 | 2003-03-06 | The Procter & Gamble Company | Absorbent article with film-like region of chitosan material |
-
2006
- 2006-04-19 WO PCT/JP2006/308214 patent/WO2006120851A1/en not_active Ceased
- 2006-04-19 JP JP2007528169A patent/JPWO2006120851A1/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5598978A (en) * | 1979-01-18 | 1980-07-28 | Keizou Ogino | Dyeing of polyamide product |
| JPS58212447A (en) * | 1982-05-26 | 1983-12-10 | シ−トン・カンパニ− | Production of coagulable porous collagen sheet material |
| JPS62110977A (en) * | 1985-11-11 | 1987-05-22 | 日本油脂株式会社 | Pearl like softener composition |
| JP2000178881A (en) * | 1998-12-15 | 2000-06-27 | Fuji Spinning Co Ltd | Processing method of cellulosic fabric |
| WO2000051561A1 (en) * | 1999-03-02 | 2000-09-08 | Kyowa Hakko Kogyo Co., Ltd. | Cosmetics |
| WO2003018073A2 (en) * | 2001-08-24 | 2003-03-06 | The Procter & Gamble Company | Absorbent article with film-like region of chitosan material |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008126782A1 (en) * | 2007-04-06 | 2008-10-23 | Kyowa Hakko Bio Co., Ltd. | Antiseptic agent for skin |
| JP5424869B2 (en) * | 2007-04-06 | 2014-02-26 | 協和発酵バイオ株式会社 | Skin disinfectant |
| US8338404B2 (en) * | 2007-09-11 | 2012-12-25 | Kyowa Hakko Bio Co., Ltd. | Composition and method for reducing allergen |
| JP2009270208A (en) * | 2008-05-01 | 2009-11-19 | Ohara Palladium Kagaku Kk | Antibacterial deodorant processing agent for fiber and textile product processed with the processing agent |
| ITVR20120104A1 (en) * | 2012-05-22 | 2013-11-23 | Paolo Srl O | PROCESS OF TREATMENT OF FABRICS INTENDED TO GO TO CONTACT WITH THE HUMAN BODY |
| WO2014007290A1 (en) * | 2012-07-03 | 2014-01-09 | 味の素株式会社 | Moisturizer and cosmetic containing same |
| US9456971B2 (en) | 2012-07-03 | 2016-10-04 | Ajinomoto Co., Inc. | Moisturizer and cosmetic agent containing same |
| JP2018202170A (en) * | 2017-06-02 | 2018-12-27 | 三洋化成工業株式会社 | Absorbent article |
| JP2018202165A (en) * | 2017-06-02 | 2018-12-27 | 三洋化成工業株式会社 | Absorbent articles |
| WO2019012744A1 (en) | 2017-07-14 | 2019-01-17 | 信越化学工業株式会社 | Functional-agent-containing fiber and method for manufacturing same |
| KR20200029446A (en) | 2017-07-14 | 2020-03-18 | 신에쓰 가가꾸 고교 가부시끼가이샤 | Functional agent-containing fiber and method for manufacturing same |
| US11834779B2 (en) | 2017-07-14 | 2023-12-05 | Shin-Etsu Chemical Co., Ltd. | Functional-agent-containing fiber and method for manufacturing same |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2006120851A1 (en) | 2008-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102803588B (en) | Iodine- and amylase-containing fibers, process for production thereof, and use thereof | |
| CN102822413A (en) | Process of treatment of fibers and/or textile materials | |
| WO2006120851A1 (en) | Agent for imparting functions to textile products | |
| JP7317822B2 (en) | Hair care composition containing silk fibroin | |
| JP2001200478A (en) | Fiber-treating agent and method for treating fiber | |
| JP2010090523A (en) | Antibacterial deodorization-bacteriostatic processing method for fibrous structure | |
| US20050054251A1 (en) | Undergarments containing active substances | |
| JP3022880B1 (en) | Clothing for promoting metabolism of stratum corneum and method for attaching microcapsules | |
| JP3038202B1 (en) | Functional fiber, method for producing the same, and processing solution for functional fiber | |
| JP4217104B2 (en) | Agent for imparting skin care effect to textile product, and method for producing textile product having skin care effect using the same | |
| KR102181905B1 (en) | Manufacturing method of Tissue for inhibiting Dye Transfer during laundering and Tissue manufactured by the method | |
| TWI279226B (en) | Dressings which can be applied several times to textile fibres and textile fabrics | |
| JP2004067586A (en) | Antimicrobial agent composition and antimicrobial sheet-like article using the same | |
| JP2001172861A (en) | Method and composition for fixing functional agent to fiber | |
| KR20040085417A (en) | Fabric softener composition | |
| US20250230203A1 (en) | Fibroin peptides and protein fragments compositions | |
| EP1550705B1 (en) | Allergen inactivator | |
| JP5621223B2 (en) | Deodorant | |
| JP3893116B2 (en) | Allergen reducing agent | |
| JP2001020179A (en) | Fibrous material | |
| JP2002069848A (en) | Fiber treatment agent, fiber treatment method and fiber product | |
| JP2006307380A (en) | Fiber-processing agent and fiber product using the same | |
| BR112017011730B1 (en) | cosmetic process of treatment of odors of the human body, polymer, composition and deodorization processes | |
| JPH11107163A (en) | Fiber treating agent, fiber or fiber raw cloth, and surface material for sanitary good | |
| JP2019019085A (en) | Antiviral agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2007528169 Country of ref document: JP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| NENP | Non-entry into the national phase |
Ref country code: RU |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 06745446 Country of ref document: EP Kind code of ref document: A1 |